Navigation Links
Inverness Medical Innovations Announces Fourth Quarter 2007 Results
Date:2/20/2008

diluted net loss per

common share under GAAP because inclusion thereof would be

antidilutive.

(l) Included in the weighted average diluted common shares for the

calculation of diluted net income per common share for the year

ended December 31, 2007, on an adjusted cash basis, are dilutive

shares consisting of 2,726,000 common stock equivalent shares from

the potential exercise of stock options and awards and warrants.

The diluted net income per common share calculation for the year

ended December 31, 2007, on an adjusted cash basis, does not

include 1,807,000 common stock equivalent shares from the potential

conversion of convertible debt, as inclusion thereof would be

antidilutive.

(m) Included in the weighted average diluted common shares for the

calculation of diluted net income per common share for the year

ended December 31, 2006, on an adjusted cash basis, are dilutive

shares consisting of 1,469,000 common stock equivalent shares from

the potential exercise of stock options and warrants.

Inverness Medical Innovations, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

(in $000s)

December 31, December 31,

2007 2006

ASSETS

CURRENT ASSETS:

Cash and cash equivalents $414,732 $71,104

Restricted cash 141,869 -

Marketable securities 2,551 -

Accounts receivable, net 163,380 100,388

Inventories, net 148,231 78,322

Prepaid expenses
'/>"/>

SOURCE Inverness Medical Innovations
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Inverness Medical Innovations Completes Acquisition of BBI Holdings Plc
2. Correction to Press Release Dated January 31, 2008: Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
3. Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
4. Inverness Medical Innovations to Participate at JP Morgan Healthcare Conference on January 8, 2008
5. Inverness Medical Innovations Acquires ParadigmHealth
6. Inverness Medical Innovations Agrees to Acquire ParadigmHealth
7. Inverness Medical Innovations Announces Proposed Public Offering of Common Stock
8. Inverness - Chemogen Establish Exclusive License for TB Antibodies
9. Inverness Medical Innovations Agrees to Acquire Panbio Ltd.
10. B-Line Medical and Immersion Medical Announce Partnership
11. MIT researcher addresses biomedical engineering challenges
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... to a chain of carbon atoms can turn it ... Rice University scientists. , Stretching the material known as ... -- by just 3 percent can begin to change ... for mechanically activated nanoscale electronics and optics. , The ... colleagues appears in the American Chemical Society journal ...
(Date:7/21/2014)... (July 21, 2014) The yield so far ... have developed a low-energy, solution-based mineral substitution process to ... find use in electronics and alternative energy devices. , ... cover of the July 21 issue of the journal ... of research in the inorganic and nuclear chemistry fields. ...
(Date:7/21/2014)... New York , July 21, 2014 /PRNewswire/ ... research on Global & USA ... Size, Trends, and Forecasts ResearchMoz presents ... Cancer Biomaker Market   to 2018 (Identification, Technologies, Market ... Industry Trends, and Pipeline Analysis. GLOBAL ...
(Date:7/20/2014)... recycled, the process releases radioactive krypton and xenon gases. ... related gas radon. A new porous material called CC3 ... in Nature Materials shows how: by breathing ... , The CC3 material could be helpful in ... or air in buildings and also in recycling useful ...
Breaking Biology Technology:Carbyne morphs when stretched 2Carbyne morphs when stretched 3Oregon chemists eye improved thin films with metal substitution 2Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 2Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 3Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 4Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 5Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 6A noble gas cage 2A noble gas cage 3
... Fla., March 27 Catalyst Pharmaceutical Partners, Inc. ... that acquires, in-licenses, develops and commercializes prescription drugs ... financial results for the fourth quarter and year ... 2008," said Patrick J. McEnany, Chief Executive Officer ...
... track their cholesterol and, more importantly, lower their cholesterol by putting ... modifiable risk factors for high cholesterol. , ... Melbourne, ... Cholesterol Coach onto the iTunes App Store. , ,High cholesterol ...
... which dramatically improves the sensitivity of Magnetic Resonance techniques ... has been developed by scientists at the University of ... the fuel of the space shuttle, is expected to ... condition from an MRI scan at lower cost while ...
Cached Biology Technology:Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2008 Financial Results 2Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2008 Financial Results 3Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2008 Financial Results 4Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2008 Financial Results 5Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2008 Financial Results 6First Application to Fight High Cholesterol Launches on the iPhone and iPod Touch 2Transforming medical diagnosis with new scanning technology 2
(Date:7/22/2014)... researchers in modifying properties of nanomaterials for application in ... to recent innovative studies conducted by scientists from the ... of a simple, efficient and low cost technique involving ... by Professor Sow Chorng Haur from the Department of ... the properties of two different types of materials can ...
(Date:7/22/2014)... and Shenzhen, China July 22, 2014 ... subsidiary of BGI, the world,s largest genomics organization, ... human whole exome sequencing service based on Complete ... in-depth bioinformatics analysis and SNP validation, and is ... , Complete Genomics, highly regarded in the ...
(Date:7/22/2014)... a child,s lunch box and you,re likely to find that ... Those are the findings of a study conducted by researchers ... Tufts University and in the Department of Public Health and ... findings are published online ahead of print in the ... , Led by senior author Jeanne Goldberg, Ph.D., R.D., a ...
Breaking Biology News(10 mins):NUS scientists use low cost technique to improve properties and functions of nanomaterials 2NUS scientists use low cost technique to improve properties and functions of nanomaterials 3BGI Tech launches human whole exome sequencing service on complete genomics' advanced platform 2Room for improvement in elementary school children's lunches and snacks from home 2
... factor for stroke, and its occurrence is closely related ... animals have shown that scavenger receptor class B type ... of scavenger receptor class B type I gene polymorphisms ... the exon 8 C1050T polymorphism, and these polymorphic loci ...
... During the last decade, our understanding of ... novel hypothalamic Arg-Phe-amide- related peptides, kisspeptin and ... the reproductive axis. Kisspeptins are currently recognized ... hypothalamus-pituitary-gonadal axis. Kisspeptin and its receptor, G ...
... The Bert L. and N. Kuggie Vallee Foundation announces, ... The 2013 winners are: Dr. Kirsty L. ... Molecular Biology at the Karolinska Institutet (Stockholm, Sweden) who ... fat cells. Dr. David Tobin, Assistant Professor of ...
Cached Biology News:
MOUSE ANTI HUMAN MBP (67-74) Immunogen: Human myelin basic protein...
... is designed to purify double-stranded DNA (dsDNA) generated ... PCR. The process is simple and fast. DNA ... can be efficiently purified and concentrated. The DNAclear ... bound to the Microfilter Cartridge in the presence ...
Normal donkey serum collected from healthy normal donkeys....
Whole blood is collected from canines (any breed, either sex), refrigerated within 6 hours, processed within 24 hours and frozen at -20C....
Biology Products: